Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving hydrolase
Reexamination Certificate
2001-02-09
2004-05-25
Leary, Louise N. (Department: 1654)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving hydrolase
C435S004000, C435S029000, C435S034000, C435S006120
Reexamination Certificate
active
06740499
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to the area of lower respiratory tract infections. More particularly, the present invention provides a method for differentiating bacterial versus non-bacterial exacerbations of chronic lung disease.
DISCUSSION OF RELATED ART
Chronic bronchitis and other lung diseases including cystic fibrosis and bronchiectasis, are associated with intermittent exacerbations (such as acute exacerbations of chronic bronchitis (AECB)) that lead to worsening of the chronic symptoms of productive cough and dyspnea. These exacerbations cause considerable morbidity, and in patients with concomitant airway obstruction such as chronic obstructive pulmonary disease (COPD), are a major cause of mortality (Burrows et al., 1969
, N. Engl. J. Med
., 280:397-404). AECB can have one or more of several different etiologies (Sethi, 1998
, Infect. Dis. Clin. Pract
., 7:S300-S308). Virus infection, identified by a four-fold rise in antibody titer or by viral isolation, causes a third of exacerbations (Gump et al., 1976
, Am. Rev. Respir. Dis
., 113:465-473; Buscho et al., 1978
, J. Infect. Dis
., 137:377-383; Smith et al., 1980
, Am. Rev. Respir. Dis
., 121:225-232). Serological evidence of atypical bacterial infection, mostly by
Chlamydia pneumoniae
, is seen in 5-10% of exacerbations (Blasi et al., 1993
, Eur. Respir. J
., 6:19-22; Miyashita et al., 1998
, Chest
, 114:969-971). Bacterial pathogens, especially nontypeable
Haemophilus influenzae, Streptococcus pneumoniae, Moraxella
(
Branhamella
)
catarrhalis
and
Pseudomonas aeruginosa
are isolated from sputum in about 50% of exacerbations (Sethi, 1998, supra).
The role of bacterial pathogens as a cause of AECB is controversial for several reasons. Bacterial pathogens can be isolated from sputum during stable chronic bronchitis at the same frequency as during exacerbations. Serological studies examining antibodies to common bacterial pathogens and placebo-controlled antibiotic trials in AECB have yielded confusing and contradictory results. Though alternative explanations exist for these observations, many authors have interpreted them to show that bacterial pathogens play no role in AECB (Tager et al., 1975
, N. Engl. J. Med
. 292:563-571; Murphy et al., 1992
, Am. Rev. Respir. Dis
. 146:1067-1083; Isada, 1993
, Antibiotics for chronic bronchitis with exacerbations. Seminars in Respiratory Infections
. 8:243-253; Nicotra et al., 1993
, Antibiotic use in exacerbations of chronic bronchitis. Seminars in Respiratory Infections
. 8:254-258). This view holds that isolation of bacteria during AECB represents chronic colonization and is a mere epiphenomenon.
The absence of a more definitive and quick indication regarding the involvement of bacterial induced exacerbation of chronic lung disease makes the choice of treatment options difficult. Culturing of sputum to identify bacterial involvement is time consuming. Thus, there is an ongoing need for identifying markers that provide a simple and quick test to distinguish between different etiological causes of exacerbations of chronic lung disease, in particular to distinguish between bacterial and non-bacterial induced exacerbations.
SUMMARY OF THE INVENTION
The present invention provides a simple and quick test for discriminating between bacterial and non-bacterial exacerbations of chronic lung disease. The test is based on the unexpected observation of a strong correlation between bacterial AECB and sputum elastase. Thus, the test comprises obtaining a sputum sample from an individual such that it contains secretions of the lower respiratory tract, and testing it for the presence of elastase. For certain pathogens, a correlation is also observed between AECB and sputum IL-8 or TNF-&agr;. Thus, in another embodiment, the levels of IL-8 or TNF-&agr; may be tested. The amount of these markers is then compared to standard reference. The comparison may be done using a calorimeter or by visual means.
REFERENCES:
patent: 5686070 (1997-11-01), Doerschuk et al.
Matsumoto, K; Verhandelingen-Koninklijke Academie voor Geneeskunde van Belgie [Verh K Acad Geneeskd Belg] 1995; V 57(2), pp. 109-122, (Abstract Only).*
Mikami, M; Nihon Kyobu Shikkan Gakkai zasshi[Nihon Kyobu Shikkan Gakkai Zasshi] 1991 Jan.; V. 29(1), pp. 72-83, (Abstract Only).*
Tsang et al, Chest, V117/2, pp. 420-426 (Feb., 2000).*
Burrows, et al, Course and Prognosis of Chronic Obstructive Lung Disease, 1969, N. Engl. J. Med., vol. 280, pp. 397-404.
Sethi, Management of Acute Exacerbations of Chronic Bronchitis, 1998, Infect. Dis. Clin, Pract., 1998, 7:S300-S308.
Tager, et al., Role of Infection in Chronic Bronchitis, 1975, N. Engl. J. Med., vol. 292, No. 11, pp. 563-571.
Murphy et al., Bacterial Infection in Chronic Obstructive Pulmonary Disease, 1992, Am. Rev. Respir. Dis., 146:1067-1083.
Isada, Pro: Antibiotics for Chronic Bronchitis With Exacerbations, 1993, Seminars in Respiratory Infections, vol. 8, No. 4, pp. 243-253.
Nicotra et al., Con: Antibiotic Use in Exacerbations of Chronic Bronchitis, 1993, Seminars in Respiratory Infections, vol. 8, No. 4, pp. 254-258.
Pevnitsky, et al. Immunological Monitoring of Patients with Cystic Fibrosis: Value of Different Laboratory Findings. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, 2000, vol. 5, pp. 40-46, see English Abstract p. 46.
Elborn, et al. Host Inflammatory Responses to First Isolation of Pseudomonas Aerugonoisa from Sputum in Cystic Fibrosis. Pediatric Pulmonology. 1993, vol. 15, pp. 287-291, see entire document.
Kudo, et al. Activity and Inhibitors in Sputum from Chronic Respiratory Diseases. Therapeutic Research. 1988, vol. 8, No. 2, pp. 526-533, see English Abstract on p. 533.
Kudo, Y. Elastolytic Activity and Inhibitors in Sputum from Chronic Respiratory Diseases. Tokyo Joshi Ika Daigaku Zasshi. 1991, vol. 61, No. 2, pp. 124-132, see English Abstract on p. 124.
Crooks, et al. Bronchial Inflammation in Acute Bacterial Exacerbations of Chronic Bronchitis: The Role of Leukotriene B4.Eur. Respir. J. 2000, vol. 15, pp. 274-280, see entire document.
Tsang, et al. Sputum Elastase in Steady-State Bronchiectasis. Chest. Feb. 2000, vol. 117, pp. 420-426, see entire document.
Hill, et al. The Interrelationship of Sputum Inflammatory Markers in Patients with Chronic Bronchitis. Am. J. Respir. Crit. Care. Med. 1999, vol. 160, pp. 893-898, see entire document.
Pukhalsky, et al. Inflammatory Markers in Cystic Fibrosis Patients with Lung Pseudomonas Aeruginosa Infection. Mediators of Inflammation. 1999, vol. 8, pp. 159-167, see entire document.
Sethi et al,Comparison of Airway Inflammation in Acute Bacterial and Non-Bacterial Exacerbations of COPD, American Journal of Respiratory and Critical Care Medicine, Mar. 1999, vol. 159, No. 3.
Murphy Timothy F.
Sethi Sanjay
Hodgson & Russ LLP
Leary Louise N.
The Research Foundation of State University of New York
LandOfFree
Method for detecting bacterial exacerbations of chronic lung... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting bacterial exacerbations of chronic lung..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting bacterial exacerbations of chronic lung... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3226978